Linden Thomas Advisory Services, LLC

Position in ABBV — AbbVie Inc.

CIK 1965702 Charlotte, NC

Position in ABBV

as of Jun 30, 2026 · filed Jul 16, 2026 Compact

Position Value

$3,784,917

+$668,068 QoQ

Shares Held

15,041

+5.0% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.31%

of 13F equity value

Holder Rank

#1,492

of 4,153 holders

Holding Since

Dec 2022

15 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Linden Thomas Advisory Services, LLC holds $22,830,139 across 6 Drug Manufacturers - General names. ABBV ranks #2 (16.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	6,333	$7,595,990
2	ABBV	AbbVie Inc. This page	15,041	$3,784,917
3	GILD	Gilead Sciences, Inc.	27,150	$3,430,131
4	MRK	Merck & Co., Inc.	25,106	$3,226,121
5	AMGN	Amgen Inc	8,364	$3,028,771
6	BMY	Bristol Myers Squibb Co	30,618	$1,764,209

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$3,784,917	15,041	+5.0%	Shares	Sole	2026-07-16
2026-03-31	$3,116,849	14,331	+6.1%	Shares	Sole	2026-04-10
2025-12-31	$3,086,214	13,507	+3.1%	Shares	Sole	2026-01-16
2025-09-30	$3,033,174	13,100	+1.2%	Shares	Sole	2025-11-06
2025-06-30	$2,403,407	12,948	+4.5%	Shares	Sole	2025-07-31
2025-03-31	$2,595,324	12,387	+0.4%	Shares	Sole	2025-04-30
2024-12-31	$2,192,462	12,338	+0.3%	Shares	Sole	2025-01-21
2024-09-30	$2,429,596	12,303	-0.3%	Shares	Sole	2024-10-17
2024-06-30	$2,116,556	12,340	-1.7%	Shares	Sole	2024-07-10
2024-03-31	$2,286,629	12,557	+0.8%	Shares	Sole	2024-04-30
2023-12-31	$1,931,391	12,463	+1.0%	Shares	Sole	2024-02-01
2023-09-30	$1,839,698	12,342	-0.1%	Shares	Sole	2023-10-20
2023-06-30	$1,664,723	12,356	+2.9%	Shares	Sole	2023-07-27
2023-03-31	$1,914,193	12,011	+11.0%	Shares	Sole	2023-04-25
2022-12-31	$1,748,135	10,817	—	Shares	Sole	2023-02-17
No filing history on record for this holder in this stock.